Current evidence for second-line treatment in metastatic renal cell carcinoma after progression to immune-based combinations
Roberto Iacovelli, Chiara Ciccarese, Giuseppe Procopio, Serena Astore, Maria Antonella Cannella, Maria Grazia Maratta, Mimma Rizzo, Elena Verzoni, Camillo Porta, Giampaolo Tortora
Topics & Concepts
MedicineRenal cell carcinomaRegimenSecond lineOncologyClinical trialIntensive care medicineInternal medicineFirst lineRenal cell carcinoma treatmentCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis